Enrofloxacin induces intestinal disorders of metabolome and microbiome in American shad (Alosa sapidissima)

11Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Enrofloxacin (ENR) has been often detected in the environment and organisms due to its widespread use in aquaculture, medical cosmetology and animal husbandry. Though the effects of ENR exposure on the gut microbiome of aquaculture fish have been reported, there is little information on the long-term impact on adult American shad. In this study, ENR (100 mg/kg) exposed to American shad for 30 days. Then, we monitored the alterations in the gut microbiome, the responses on metabolomic and the change in the body weight. ENR exposure affected the composition of the gut microbiota community and altered community diversity. The LC-MS analysis showed the changes in several metabolic pathways, including lipid metabolism, the cellular process pathways, immune system and amino acid metabolism pathway. These metabolic pathways were related to increasing body weight gain through fat accumulation. In conclusion, this study provides evidence that ENR exposure can increase the body weight in American shad and yield new information on the effects of ENR exposure on the aquatic system.

Cite

CITATION STYLE

APA

Du, J., & Liu, Q. (2021). Enrofloxacin induces intestinal disorders of metabolome and microbiome in American shad (Alosa sapidissima). Aquaculture Research, 52(12), 6571–6580. https://doi.org/10.1111/are.15528

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free